CompletedNot applicableNCT03052491
Effects of a 10 Component Dietary Supplement on Health and the Quality of Life
Studying Familial articular hypermobility syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centagen, Inc.
- Principal Investigator
- Bryant Villeponteau, Ph.D.Centagen, Inc.
- Intervention
- Stem Cell 100+(dietary_supplement)
- Enrollment
- 15 enrolled
- Eligibility
- 35-80 years · All sexes
- Timeline
- 2016 – 2016
Study locations (1)
- Accelagen, Inc., San Diego, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03052491 on ClinicalTrials.govOther trials for Familial articular hypermobility syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06277401Exercise in Patients With Hypermobile Joints and Knee PainUniversity of Southern Denmark
- RECRUITINGNCT05698446Comparison of MBR + Suture Tape, MBR, and Anatomic Reconstruction for CLAI in GJL Cases: A Prospective Cohort StudyPeking University Third Hospital
See all trials for Familial articular hypermobility syndrome →